Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DISA ( (SG:532) ) just unveiled an announcement.
Digital Life Line, a subsidiary of DISA Limited, has signed a memorandum of understanding with Vietnam-based OneMedic to run a proof-of-concept pilot for AI-powered community vision screening. The collaboration aims to integrate DLL’s portable Automated Visual Acuity Test and MIDAS cataract screening devices into OneMedic’s AI healthcare platform to address a shortage of specialist eye care and limited clinic infrastructure in rural areas.
The pilot will test the feasibility and effectiveness of delivering fast, accurate and scalable eye screening through an integrated, portable workflow deployed in community healthcare settings. It also seeks to generate a comprehensive vision health dataset from underserved populations in Vietnam, supporting evidence-based public health planning and potentially strengthening DISA’s position in AI-enabled healthcare solutions when the project begins, targeted for February 2026, subject to final implementation terms.
The most recent analyst rating on (SG:532) stock is a Sell with a S$0.01 price target. To see the full list of analyst forecasts on DISA stock, see the SG:532 Stock Forecast page.
More about DISA
DISA Limited is a Singapore-listed technology group focused on deploying cutting-edge innovations such as artificial intelligence and the Internet of Things to improve outcomes, reduce costs and boost efficiency in the healthcare and consumer sectors. Through strong in-house research and development, the company develops scalable digital solutions and connected devices that support the digitalisation of products and services across its target markets.
Current Market Cap: S$14.09M
Learn more about 532 stock on TipRanks’ Stock Analysis page.